DOI: 10.1038/ncomms15779
OPEN
Corrigendum: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action Ning Chai, Lee R. Swem, Summer Park, Gerald Nakamura, Nancy Chiang, Alberto Estevez, Rina Fong, Lynn Kamen, Elviza Kho, Mike Reichelt, Zhonghua Lin, Henry Chiu, Elizabeth Skippington, Zora Modrusan, Jeremy Stinson, Min Xu, Patrick Lupardus, Claudio Ciferri & Man-Wah Tan Nature Communications 8:14234 doi: 10.1038/ncomms14234 (2017); Published 19 Jan 2017; Updated 25 May 2017 This Article contains errors in Fig. 5c. The blue squares should be labelled ‘Water þ 46B8’ and the green triangles should be labelled ‘Tamiflu þ 46B8’. The correct version of Fig. 5 appears below as Fig. 1. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ r The Author(s) 2017
NATURE COMMUNICATIONS | 8:15779 | DOI: 10.1038/ncomms15779 | www.nature.com/naturecommunications
1
CORRIGENDUM a
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15779
Minimum lethal dose
High lethal dose 100 Percent survival
Percent survival
100 80 60 40 20
80 60 Water + control IgG
40
Tamiflu + control IgG Water + 46B8
20 0
0 0
5
10
15
20
25
0
5
10
20
25
Percent BW change
120 100 80
100 80 60 –1 3 4 5 6 7 8 9 10 11 12 13 14 17
60
120
–1 3 4 5 6 7 8 9 10 11 12 13 14 17
Percent BW change
15 Day
Day
Day
Day
b
High lethal dose Treatment initiation
TCID50 ml–1
105 104
Water + control IgG
103
Water + 46B8
10
Tamiflu + control IgG Tamiflu + 46B8
2
101 3
c
4 Day
6
High lethal dose
80 60 40 20 0
0
5
10
15 Day
20
25
120 Water + control IgG 100
Tamiflu + control IgG Water + 46B8
80
Tamiflu + 46B8
60 –1 2 3 4 5 6 8 9 10 11 12 13 14 15 16 17 18 20
Percent BW change
Percent survival
100
Day
Figure 1 |
2
NATURE COMMUNICATIONS | 8:15779 | DOI: 10.1038/ncomms15779 | www.nature.com/naturecommunications